MMG
VRX

Monetary Management Group’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Monetary Management Group’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-325
Closed -$58K – 350
2015
Q3 		$58K Buy
+325
New +$58K 0.03% 212

Other funds holding VRX

AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

Monetary Management Group's VRX Position: Q4 2015 in Review

Monetary Management Group sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q4 2015, closing a stake of 325 shares — an estimated $58K sold.

Monetary Management Group first reported a position in VRX in Q3 2015 and held it in 1 quarter. The position peaked at $58K in Q3 2015. 2 funds tracked by Wall St. Rank hold VRX as of Q4 2015.

  • Monetary Management Group reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q4 2015 after selling out during the quarter.
  • Monetary Management Group sold 325 VALEANT PHARMACEUTICALS INTL shares in Q4 2015, an estimated $58K.
  • Monetary Management Group first reported a position in VALEANT PHARMACEUTICALS INTL in Q3 2015 and held it in 1 quarter.
  • Monetary Management Group's VALEANT PHARMACEUTICALS INTL position peaked at $58K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q4 2015.

Based on Monetary Management Group's 13F filing for Q4 2015, filed 11 Feb 2016.